Key Takeaway: GLP-1 medications are considered qualified medical expenses because they treat a recognized medical condition (obesity or diabetes), allowing you to pay for them using pre-tax dollars from an HSA or FSA
Mounjaro (tirzepatide) is still being studied for long-term effects, but potential risks include gastrointestinal issues (nausea, vomiting, diarrhea, constipation), gallbladder problems (such as gallstones), low blood sugar (if taken with certain diabetes medications), and potential thyroid-related concerns
The label might be small, the print might be hard to read, and if you are used to one concentration and switch pharmacies, the units-to-milligrams ratio changes completely
Should YOU Try GLP-1 Medications
As optometrists, we must be mindful of any potential adverse effects our patients medications might have on their overall health and/or on their existing health conditions